TechFlow, October 8 — According to GlobeNewswire, Predictive Oncology, a Nasdaq-listed company, announced it has completed a $343.5 million PIPE financing. The company will use the funds to purchase ATH tokens in the public market, supporting its ATH token treasury strategy. (Note: ATH is the native utility token of the Aethir ecosystem)
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号




